The Precision Health Initiative is conducted by Genuity Science. Listen to our new podcast here.

Companies involved in R&D have had to change focus quickly

If there is one thing Covid-19 has taught businesses it is to expect the unexpected and always be ready to pivot. Many companies involved in the areas of research and development (R&D) have done just that, with much of the effort and funding that would have gone towards other important programmes or trials now being flooded into research for a vaccine or treatment for Covid-19.

Dublin-based life science company Genuity Science has seen a major shift in focus of R&D, with much funding and manpower diverted solely to the Covid effort.

Anne Jones, managing director of Genuity Science (Ireland) Ltd, says: “Globally many clinical trials in other areas have been suspended, and we’ve seen many labs, particularly those in an academic setting, currently closed due to restrictions stemming from the pandemic.”

Read the full story here.